XERS Stock | | | USD 3.51 0.07 1.96% |
Xeris Pharmaceuticals financial indicator trend analysis is more than just analyzing Xeris Pharmaceuticals current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xeris Pharmaceuticals is a good investment. Please check the relationship between Xeris Pharmaceuticals Total Assets and its Current Deferred Revenue accounts. Check out
Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Xeris Stock please use our
How to Invest in Xeris Pharmaceuticals guide.
Total Assets vs Current Deferred Revenue
Total Assets vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Xeris Pharmaceuticals Total Assets account and
Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Xeris Pharmaceuticals' Total Assets and Current Deferred Revenue is 0.84. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Xeris Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Xeris Pharmaceuticals' Total Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Xeris Pharmaceuticals are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Assets i.e., Xeris Pharmaceuticals' Total Assets and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.84 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Assets
Total assets refers to the total amount of Xeris Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Xeris Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Xeris Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xeris Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Xeris Stock please use our
How to Invest in Xeris Pharmaceuticals guide.
Enterprise Value is likely to gain to about 509.5
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 79.7
M in 2024.
Xeris Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Xeris Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xeris Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Xeris Stock Analysis
When running Xeris Pharmaceuticals' price analysis, check to
measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.